Medicament antiinflamator arată rezultate promițătoare pentru depresiunea rezistentă la tratament într-un studiu clinic

Researchers conducted a small clinical trial testing an anti-inflammatory medication used for rheumatoid arthritis as a depression treatment, finding it reduced depressive symptoms, fatigue, and anxiety while improving quality of life. This approach targets immune system dysfunction rather than brain neurotransmitters, representing an emerging avenue for treating depression resistant to conventional antidepressants.